Cargando…

Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation

Objective: To analyze and summarize the clinical and imaging characteristics of patients with cytomegalovirus retinitis (CMVR) relapse after hematopoietic stem cell transplantation (HSCT). Methods: This retrospective case series study recruited patients with CMVR after HSCT. The study compared the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaona, Lu, Yao, Li, Haiping, Ma, Zhizhong, Hong, Jing, Wang, Changguan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142787/ https://www.ncbi.nlm.nih.gov/pubmed/37109025 http://dx.doi.org/10.3390/jpm13040639

Ejemplares similares

Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation
por: Kim, Joo Young, et al.
Publicado: (2020)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia
por: Zhang, Yuehong, et al.
Publicado: (2022)

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
por: Dieamant, Débora C, et al.
Publicado: (2013)

Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: Can we develop a screening protocol?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

Peripheral blood lymphocyte responses to cytomegalovirus seropositivity after allogeneic-hematopoietic stem cell transplantation
por: Zhang, Jiexin, et al.
Publicado: (2018)

Late cytomegalovirus infection after hematopoietic stem cell transplantation: case reports
por: Pinheiro, Sâmara Grapiuna, et al.
Publicado: (2013)

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
por: Ong, Shin-Yeu, et al.
Publicado: (2015)

Standardized monitoring of cytomegalovirusspecific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
por: Wagner-Drouet, Eva, et al.
Publicado: (2019)

NEOVASCULAR COMPLICATIONS FROM CYTOMEGALOVIRUS NECROTIZING RETINOPATHY IN PATIENTS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Long, Ze, et al.
Publicado: (2021)

Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
por: Cho, Sung-Yeon, et al.
Publicado: (2019)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
por: Mardani, Masoud, et al.
Publicado: (2020)

P1617: CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS DRUG RESISTANCE GENE MUTATIONS IN CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: yang, D., et al.
Publicado: (2022)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Stern, Lauren, et al.
Publicado: (2019)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
por: Wang, Huiru, et al.
Publicado: (2022)

Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
por: Xia, Jintao, et al.
Publicado: (2022)

Quantification of Cytomegalovirus Glycoprotein Bn DNA in Hematopoietic Stem Cell Transplant Recipients by Real-time PCR
por: Zhang, Xuan, et al.
Publicado: (2012)

Cytomegalovirus pneumonia in a patient with T-lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: A case report
por: Li, Qiuyu, et al.
Publicado: (2019)

1075. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
por: Prockop, Susan E., et al.
Publicado: (2023)

The Viral Load of Human Cytomegalovirus Infection in Children following Hematopoietic Stem Cell Transplant by Chip Digital PCR
por: Wang, Wen-Jun, et al.
Publicado: (2022)

Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
por: Jaing, Tang-Her, et al.
Publicado: (2019)

Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years
por: Diaz, Laura, et al.
Publicado: (2020)

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
por: Cui, Jiaqi, et al.
Publicado: (2022)

The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
por: Zakhour, Johnny, et al.
Publicado: (2022)

Presumed cytomegalovirus retinitis late after kidney transplant
por: Silva, Filipa, et al.
Publicado: (2021)

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation
por: Chen, George L., et al.
Publicado: (2023)

Evaluation of Platelet Parameters in Patients With Secondary Failure of Platelet Recovery and Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
por: Zhao, Yujian, et al.
Publicado: (2023)

Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation
por: Ye, Baning, et al.
Publicado: (2017)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation
por: Bernshtein, Biana, et al.
Publicado: (2021)

Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation
por: Zhou, Xinyi, et al.
Publicado: (2021)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
por: Li, Shan-shan, et al.
Publicado: (2022)

Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
por: Sato, Kazuya, et al.
Publicado: (2022)

Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity
por: del Rosal, Teresa, et al.
Publicado: (2022)

Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
por: Barkam, Corinna, et al.
Publicado: (2012)

Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation
por: Jin, Fengyan, et al.
Publicado: (2016)

Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation
por: Daniels, Kori, et al.
Publicado: (2019)

Continuous High-Dose (6 mg) vs. Low-Dose (3 mg) Intravitreal Ganciclovir for Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized Controlled Study
por: Chen, Wei-Bin, et al.
Publicado: (2021)

Comparison of the safety and efficacy of triple sequential therapy and transscleral cyclophotocoagulation for neovascular glaucoma in the angle-closure stage
por: Hong, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hhmsntn4bkchgouaa48dvr6o0t